The FDA has several accelerated approval programs to expedite the availability of treatments for serious conditions like cancer:
Fast Track: Facilitates the development and expedites the review of drugs that treat serious conditions and fill an unmet medical need. Breakthrough Therapy: Provides intensive guidance and expedited review for drugs that show substantial improvement over existing therapies. Accelerated Approval: Allows earlier approval of drugs based on surrogate endpoints that reasonably predict clinical benefit. Priority Review: Shortens the review timeline for drugs that offer significant improvements in treatment.
